Hypertension and Chronic Kidney Disease in the Elderly

Advances in Chronic Kidney Disease

Volumn 17, Issue 4, 2010, Pages 341-347

  Kithas, Philip A ^a   Supiano, Mark A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ambulatory blood pressure monitoring; Chronic kidney disease; Hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; AMLODIPINE PLUS BENAZEPRIL; ATENOLOL; BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE; CHLORTALIDONE; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; NITRENDIPINE; PERINDOPRIL; TORASEMIDE; VASODILATOR AGENT;

ADD ON THERAPY; AEROBIC EXERCISE; AGING; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; GERIATRIC PATIENT; HEALTH CARE COST; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY FUNCTION; LOW FAT DIET; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION; STROKE; SYSTOLIC HYPERTENSION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE;

EID: 77953743390     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2010.04.003     Document Type: Review

References (26)

1. Silva F.G. The aging kidney: a review-part 1. Int Urol Nephrol 37 (2005) 185-205
2. Verhave J.C., Fesler P., du Cailar G., et al. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 45 (2005) 586-591
3. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252
4. Supiano M.A., Hogikyan R.V., Sidani M.A., et al. Sympathetic nervous system activity and alpha-adrenergic responsiveness in older hypertensive humans. Am J Physiol 276 (1999) E519-E528
5. Sowers J.R., Whaley-Connell A., and Epstein M. Narrative Review: The emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Int Med 150 (2009) 776-783
6. Zhou X.J., Rakheja D., Yu X., et al. The aging kidney. Kidney Int 74 (2008) 710-720
7. Brenner B.M. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23 (1983) 647-655
8. Hill G.S., Heudes D., and Bariety J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int 63 (2003) 1027-1036
9. Moser M., and Feig P.U. Fifty years of thiazide diuretic therapy for hypertension. Arch Intern Med 169 (2009) 1851-1856
10. Goldstein D.S., and Sharabi Y. Neurogenic orthostatic hypotension, a pathophysiologic approach. Circulation 119 (2009) 139-146
11. Clement D.L., De Buyzere M.L., De Bacquer D.A., et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 348 (2003) 2407-2415
12. Ohkubo T., Hozawa A., Yamaguchi J., et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertension 20 (2002) 2183-2189
13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (1991) 3255-3264
14. Psaty B.M., Lumley T., Furberg C.D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 289 (2003) 2534-2544
15. Staessen J.A., Fagard R., Lutgarde T., et al. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350 (1997) 757-764
16. Medical Research Council Working Party. MRC trial of treatment of hypertension in older adults: principal results. BMJ 304 (1992) 405-412
17. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008) 1887-1898
18. Lewington S., Clarke R., Qizilbash N., et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
19. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 344 (2001) 3-10
20. Whelton P.K., Appel L.J., Espeland M.A., et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of non-pharmacologic interventions in the elderly (TONE). JAMA 279 (1998) 839-846
21. Ernst M.E., Carter B.L., Goerdt C.J., et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47 (2006) 352-358
22. Jamerson K., Weber M.A., Gl B., et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359 (2008) 2417-2428
23. Hansson L., Lindholm L.H., Ekbom T., et al. Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354 (1999) 1751-1756
24. Pepine C.J., Handberg E.M., Cooper-DeHoff R.M., et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: The International Verapamil-Trandalopril Study (INVEST): a randomized controlled trial. JAMA 290 (2003) 2805-2816
25. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
26. Mahmud A., and Feely J. Low-dose quadruple antihypertensive combination: more efficacious than individual agents-a preliminary report. Hypertension 49 (2007) 272-275